Quarterly report · Q2
4350.TEDINET S100PGSX
Period2022-04-01 → 2022-09-30
Filed2022-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥106.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥52.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥502m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥512m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥64.1bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥62.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥62.4bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥50.5bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥49.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥13.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥913m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥902m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥832m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥16.64 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.62 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.35 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.46 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.09 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 21.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥151m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥151m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥10m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥412m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥412m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥1.2bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥50.8bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥50.8bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7m |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥404m |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥65m |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥33m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥53.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥53.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥412m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥152m |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥152m |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥12m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥350m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥350m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥1.0bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥49.7bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥49.7bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥350m |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥32m |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥52.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥52.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥350m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 2906900 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.0950 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2769100 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0905 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 2506000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0819 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 2430600 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0794 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 2220400 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0726 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 1007900 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0329 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 950000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0310 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 746800 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0244 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 730200 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0238 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 481800 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0157 | |
| Number of shares held | CurrentQuarterInstant | 16749700 | |
| Shareholding ratio | CurrentQuarterInstant | 0.5477 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 63000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 30574000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 305740 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 30642600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 305740 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 63000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 63000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0020 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 63000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 63000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0020 | |
| Cash and deposits | Prior1YearInstant | 8201000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 6774000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 2891000000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 3328000000 | JPY |
| Account receivable monetization of receivable ca | Prior1YearInstant | 954000000 | JPY |
| Account receivable monetization of receivable ca | CurrentQuarterInstant | 981000000 | JPY |
| Account receivable medical income ca | Prior1YearInstant | 443000000 | JPY |
| Account receivable medical income ca | CurrentQuarterInstant | 431000000 | JPY |
| Merchandise | Prior1YearInstant | 4765000000 | JPY |
| Merchandise | CurrentQuarterInstant | 5220000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |